NANOMEDSYN
NanoMedSyn is a biotechnology company that provides a new generation of enzymes to treat lysosomal storage disorders.
NANOMEDSYN
Social Links:
Industry:
Biotechnology Health Care
Founded:
2012-11-15
Address:
Montpellier, Languedoc-Roussillon, France
Country:
France
Website Url:
http://www.nanomedsyn.com
Total Employee:
1+
Status:
Active
Contact:
33 411759617
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible WordPress Font Awesome Yoast WordPress SEO Plugin Google Maps Yoast SEO Premium Yoast Plugins AJAX Libraries API Contact Form 7
Official Site Inspections
http://www.nanomedsyn.com
- Host name: cluster011.ovh.net
- IP address: 213.186.33.40
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "NanoMedSyn"
NanoMedSyn - Therapeutic Proteins Engineering
NanoMedSyn offers a bioengineering platform using AMFA glycovectors targeting the …See details»
NanoMedSyn - Crunchbase Company Profile & Funding
NanoMedSyn is a biotechnology company that provides a new generation of enzymes to treat …See details»
NanoMedSyn - Therapeutic Proteins Engineering
NanoMedSyn was born from the fundamental research of its biologist and chemist founders …See details»
NanoMedSyn - LinkedIn
NanoMedSyn develops a new delivery platform to create first-in-class drugs by the engineering with patented AMFA vectors | NanoMedSyn was born from the fundamental research of its biologist and...See details»
NanoMedSyn Company Profile | Management and Employees List
NanoMedSyn develops an innovative Enzyme Replacement Therapy (ERT) solution to find the …See details»
NanoMedSyn - Products, Competitors, Financials, Employees, …
NanoMedSyn specializes in therapeutic protein engineering within the biotechnology sector. …See details»
NanoMedSyn - Treatment for Lysosomal Storage Disorders
New way to treat with glycovectors. Home; About us. History; People; Our science; Partnering; …See details»
NANOMEDSYN (MONTPELLIER) Chiffre d'affaires, résultat, bilans …
NANOMEDSYN, société par actions simplifiée, immatriculée sous le SIREN 789145760, est en …See details»
NANOMEDSYN - Eurobiomed
NanoMedSyn répond aux besoins médicaux non satisfaits grâce à des avantages compétitifs …See details»
NanoMedSyn - VentureRadar
NanoMedSyn is a biopharmaceutical Deep Tech company focused on the creation and the …See details»
NanoMedSyn | BIO-Europe Spring - Informa Connect
NanoMedSyn develops proprietary vectors for drug delivery and protein degraders. Our drug …See details»
Mannose 6‐phosphonate labelling: A key for processing the …
Jul 10, 2019 · In Pompe disease, the current enzyme replacement therapy based on a human …See details»
NanoMedSyn - Therapeutic Proteins Engineering
T hanks to their expertise in chemistry and drug delivery, NanoMedSyn’s founders have built a …See details»
Shire and NanoMedSyn to partner for enzyme replacement …
Mar 26, 2018 · Shire and NanoMedSyn to partner for enzyme replacement therapy research. …See details»
Therapy for Fabry, Other Disorders Focus of Shire, Nanomedsyn …
Apr 3, 2018 · Biotechnology companies Shire and NanoMedSyn are collaborating on research …See details»
Research programme: lysosomal storage disease therapeutics
Orphan designation is assigned by a regulatory body to encourage companies to develop …See details»
NanoMedSyn - Therapeutic Proteins Engineering
NanoMedSyn provides a technological platform to generate a range of new drugs to develop …See details»
AMFA-mAbs(NanoMedSyn) - Drug Targets, Indications, Patents
AMFA-mAbs(NanoMedSyn): a IGF-2R inhibitors Drug, Initially developed by NanoMedSyn …See details»
Shire and NanoMedSyn Enter into Research Collaboration for …
Mar 26, 2018 · Shire said it entered into a preclinical research collaboration with NanoMedSyn …See details»
News - nanomedsyn
Mar 20, 2024 · NanoMedSyn is classified as a DEEPTECH company by Bpifrance for its …See details»